Pharmafile - Medical Communications News
A new report published in The Lancet has revealed that all forms of pollution are linked with 9 million deaths worldwide in 2015 alone. Air pollution...
Giliad's Yesarta becomes second FDA-approved CAR T treatment and AstraZeneca admits efficacy data for an acquired cancer drug was fabricated. Check...
Research from scientists at the Wellcome Trust Sanger Institute has found that only between one and 10 genetic mutations are the driver behind many...
Israeli drugmaker Teva has again become embroiled in a scandal investigated by the Ontario government for allegedly bribing pharmacies to stock its...
Celgene took a gamble when it spent $710 million up-front on an inflammatory disorder treatment, but it now looks likely to have been an expensive...
A report from the BBC has found that 505 registered organ donors had their decision blocked by relatives, over the past five years. Last year, 457...
Vir biotech has managed to drum up $500 million in financing, acquire a company and strike agreements with two companies to develop clinical and...
Two studies published separately by the BBC and the Care Quality Commission point to growing problems across NHS services in the UK, with increased...
It was a mixed bag for Johnson & Johnson on its announcement of third quarter results. It could largely be broken down into two areas: in the...
The EMA received a broadside just less than two week ago from a group of researchers that had studied data from cancer drug approvals, and has now...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
